[CIS PIDD] [cis-pidd] Eye disease in CVID

CIS-PIDD cis-pidd at lists.clinimmsoc.org
Wed Nov 30 11:36:06 EST 2016


In the GvH setting, we've used cyclosporine eye drops (restasis). There was a study on a CsA implant, but I don't think that that is commercially available (paper attached). If the ophthalmologist wants objective evidence of ocular autoimmunity prior to using restasis, he could do a meibomian gland biopsy. A number of meibographic techniques have been described as well, and the ophthalmologist might be familiar with that as a non-invasive alternative
-R


--
Rob Sokolic, MD
Medical Officer
Center for Biologics Evaluation and Research
Office of Tissues and Advanced Therapies
U.S. Food and Drug Administration
Tel: 240-402-5564
Robert.Sokolic at fda.hhs.gov<mailto:Robert.Sokolic at fda.hhs.gov>
[cid:image001.png at 01D1C57E.DFA022A0]<http://www.fda.gov/>

[cid:image002.jpg at 01D1C57E.DFA022A0]<https://www.facebook.com/FDA>  [cid:image003.jpg at 01D1C57E.DFA022A0] <https://twitter.com/US_FDA>   [cid:image004.jpg at 01D1C57E.DFA022A0] <http://www.youtube.com/user/USFoodandDrugAdmin>   [cid:image005.jpg at 01D1C57E.DFA022A0] <http://www.flickr.com/photos/fdaphotos/>   [cid:image006.jpg at 01D1C57E.DFA022A0] <http://www.fda.gov/AboutFDA/ContactFDA/StayInformed/RSSFeeds/default.htm>

The above transmission is meant solely for the addressee. The information contained in this message may be of a private, medical, privileged or industrial nature, and may not be communicated beyond the initial recipient. If you are not the intended recipient of this message or the agent of such recipient, please destroy all physical copies of this message, delete all electronic copies and notify the sender of the error.

This communication does not constitute a written advisory opinion under 21 CFR 10.85, but rather is an informal communication under 21 CFR 10.85(k) which represents my best judgment at this time, but does not necessarily represent the formal position of FDA, and does not bind or otherwise obligate or commit the agency to the views expressed.


From: CIS-PIDD [mailto:cis-pidd at lists.clinimmsoc.org]
Sent: Wednesday, November 30, 2016 11:14 AM
To: CIS-PIDD
Subject: [cis-pidd] Eye disease in CVID

Dear colleagues,

We have a 55-yo white female with CVID, who has suffered from severe bilateral blepharitis, episcleritis, and dry eye for 2 years now to the point that she has lost all eyelashes. So far there is no evidence of uveitis or retinal diseases. No improvement from steroids eye drops or oral.

Her ophthalmologist is at a loss in how to proceed. I was wondering if her eyelid and scleral diseases are related to CVID. She is otherwise doing well from infection standpoint, IgG levels >1,000 on IVIG, IgA 10s, and IgM 20-30s. She does not have dry mouth, autoimmune manifestations, or lymphoid infiltrations. Her T, B cell counts and their subsets are normal.

Does anyone have experience with CVID patients like this? I would appreciate comments or suggestions. I looked up the literature and most reports of eye diseases in CVID are more of uveitis or retinal diseases, similar to those seen in sarcoidosis.

Thank you,
Panida

Panida Sriaroon, MD
Associate Professor
Associate Director, Fellowship Program
Medical Director, USF/All Children's Hospital Allergy/Immunology clinic
E-mail  psriaroo at health.usf.edu<mailto:psriaroo at health.usf.edu>



---

You are currently subscribed to cis-pidd as: Robert.Sokolic at fda.hhs.gov<mailto:Robert.Sokolic at fda.hhs.gov>.

To unsubscribe click here: http://cts.dundee.net/u?id=96396896.aa2a546ec4607db5083cfc5e6c9c7870&n=T&l=cis-pidd&o=4031955

(It may be necessary to cut and paste the above URL if the line is broken)

or send a blank email to leave-4031955-96396896.aa2a546ec4607db5083cfc5e6c9c7870 at lyris.dundee.net<mailto:leave-4031955-96396896.aa2a546ec4607db5083cfc5e6c9c7870 at lyris.dundee.net>

---
You are currently subscribed to cis-pidd as: pagid at list.clinimmsoc.org.
To unsubscribe click here: http://cts.dundee.net/u?id=96396833.5a9591ccd1e327fe6bc4d1543298c482&n=T&l=cis-pidd&o=4031996
or send a blank email to leave-4031996-96396833.5a9591ccd1e327fe6bc4d1543298c482 at lyris.dundee.net
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <https://pairlist7.pair.net/pipermail/pagid/attachments/20161130/4998caf6/attachment-0001.html>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: image001.png
Type: image/png
Size: 4087 bytes
Desc: image001.png
URL: <https://pairlist7.pair.net/pipermail/pagid/attachments/20161130/4998caf6/attachment-0001.png>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: image002.jpg
Type: image/jpeg
Size: 754 bytes
Desc: image002.jpg
URL: <https://pairlist7.pair.net/pipermail/pagid/attachments/20161130/4998caf6/attachment-0005.jpg>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: image003.jpg
Type: image/jpeg
Size: 776 bytes
Desc: image003.jpg
URL: <https://pairlist7.pair.net/pipermail/pagid/attachments/20161130/4998caf6/attachment-0006.jpg>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: image004.jpg
Type: image/jpeg
Size: 784 bytes
Desc: image004.jpg
URL: <https://pairlist7.pair.net/pipermail/pagid/attachments/20161130/4998caf6/attachment-0007.jpg>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: image005.jpg
Type: image/jpeg
Size: 790 bytes
Desc: image005.jpg
URL: <https://pairlist7.pair.net/pipermail/pagid/attachments/20161130/4998caf6/attachment-0008.jpg>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: image006.jpg
Type: image/jpeg
Size: 736 bytes
Desc: image006.jpg
URL: <https://pairlist7.pair.net/pipermail/pagid/attachments/20161130/4998caf6/attachment-0009.jpg>


More information about the PAGID mailing list